GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parenteral Drugs (India) Ltd (BOM:524689) » Definitions » Pretax Margin %

Parenteral Drugs (India) (BOM:524689) Pretax Margin % : 1,083.44% (As of Mar. 2022)


View and export this data going back to 2001. Start your Free Trial

What is Parenteral Drugs (India) Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Parenteral Drugs (India)'s Pre-Tax Income for the three months ended in Mar. 2022 was ₹192.11 Mil. Parenteral Drugs (India)'s Revenue for the three months ended in Mar. 2022 was ₹17.73 Mil. Therefore, Parenteral Drugs (India)'s pretax margin for the quarter that ended in Mar. 2022 was 1,083.44%.

The historical rank and industry rank for Parenteral Drugs (India)'s Pretax Margin % or its related term are showing as below:


BOM:524689's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.33
* Ranked among companies with meaningful Pretax Margin % only.

Parenteral Drugs (India) Pretax Margin % Historical Data

The historical data trend for Parenteral Drugs (India)'s Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parenteral Drugs (India) Pretax Margin % Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -53.72 -566.90 -589.95 -1,269.55 -1,284.39

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,298.11 -1,400.83 -1,831.88 -3,066.57 1,083.44

Competitive Comparison of Parenteral Drugs (India)'s Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Parenteral Drugs (India)'s Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parenteral Drugs (India)'s Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parenteral Drugs (India)'s Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Parenteral Drugs (India)'s Pretax Margin % falls into.



Parenteral Drugs (India) Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Parenteral Drugs (India)'s Pretax Margin for the fiscal year that ended in Mar. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2022 )/Revenue (A: Mar. 2022 )
=-1091.26/84.963
=-1,284.39 %

Parenteral Drugs (India)'s Pretax Margin for the quarter that ended in Mar. 2022 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2022 )/Revenue (Q: Mar. 2022 )
=192.105/17.731
=1,083.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parenteral Drugs (India)  (BOM:524689) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Parenteral Drugs (India) Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Parenteral Drugs (India)'s Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Parenteral Drugs (India) (BOM:524689) Business Description

Traded in Other Exchanges
N/A
Address
Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.

Parenteral Drugs (India) (BOM:524689) Headlines

No Headlines